0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Breast Cancer
 101-120 of 767 Articles
JAMA | 
Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2015;314(20):2122. doi:10.1001/jama.2015.15119.

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;314(17):1788. doi:10.1001/jama.2015.13935.

JAMA Oncology | 
Editorial | 
Wendy Y. Chen, MD, MPH
JAMA Oncol. 2015;1(8):1037-1038. doi:10.1001/jamaoncol.2015.3286.

JAMA Oncology | 
Original Investigation | 
Diana L. Miglioretti, PhD; Weiwei Zhu, MS; Karla Kerlikowske, MD; et al.
JAMA Oncol. 2015;1(8):1069-1077. doi:10.1001/jamaoncol.2015.3084.

JAMA Internal Medicine | 
Invited Commentary | 
Joshua J. Fenton, MD, MPH
JAMA Intern Med. 2015;175(11):1837-1838. doi:10.1001/jamainternmed.2015.5319.

JAMA Internal Medicine | 
Original Investigation | 
Constance D. Lehman, MD, PhD; Robert D. Wellman, MS; Diana S. M. Buist, PhD; et al.
JAMA Intern Med. 2015;175(11):1828-1837. doi:10.1001/jamainternmed.2015.5231.

JAMA Internal Medicine | 
Original Investigation | 
Estefanía Toledo, MD, MPH, PhD; Jordi Salas-Salvadó, MD, PhD; Carolina Donat-Vargas, PharmD; et al.
JAMA Intern Med. 2015;175(11):1752-1760. doi:10.1001/jamainternmed.2015.4838.
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary | 
Leisha A. Emens, MD, PhD
JAMA Oncol. 2015;1(8):1095-1097. doi:10.1001/jamaoncol.2015.2733.

JAMA Oncology | 
Review | 
Mark M. Moasser, MD; Ian E. Krop, MD, PhD
JAMA Oncol. 2015;1(8):1154-1161. doi:10.1001/jamaoncol.2015.2286.

JAMA Oncology | 
Review | 
Sibylle Loibl, MD, PhD; André Schmidt, PhD; Oreste Gentilini, MD; et al.
JAMA Oncol. 2015;1(8):1145-1153. doi:10.1001/jamaoncol.2015.2413.
Includes: CME, Supplemental Content

JAMA Oncology | 
Viewpoint | 
Steven A. Narod, MD
JAMA Oncol. 2015;1(8):1033-1034. doi:10.1001/jamaoncol.2015.2247.

JAMA Oncology | 
Original Investigation | 
Christopher R. Heery, MD; Nuhad K. Ibrahim, MD; Philip M. Arlen, MD; et al.
JAMA Oncol. 2015;1(8):1087-1095. doi:10.1001/jamaoncol.2015.2736.
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint | 
Oreste Gentilini, MD; Umberto Veronesi, MD
JAMA Oncol. 2015;1(8):1031-1032. doi:10.1001/jamaoncol.2015.2337.

JAMA Oncology | 
Invited Commentary | 
Allison W. Kurian, MD, MSc; Christopher R. Friese, PhD, RN
JAMA Oncol. 2015;1(8):1109-1110. doi:10.1001/jamaoncol.2015.2719.

JAMA Oncology | 
Original Investigation | 
Michaela A. Dinan, PhD; Xiaojuan Mi, PhD; Shelby D. Reed, PhD; et al.
JAMA Oncol. 2015;1(8):1098-1109. doi:10.1001/jamaoncol.2015.2722.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  Open Access
Kathryn Puxty, MBChB; Philip McLoone, BSc; Tara Quasim, MD; et al.
JAMA Oncol. 2015;1(8):1078-1085. doi:10.1001/jamaoncol.2015.2855.
Includes: Supplemental Content

JAMA Dermatology | 
Editorial | 
Peter J. Franks, PhD; Christine J. Moffatt, PhD, RN
JAMA Dermatol. 2015;151(11):1181-1182. doi:10.1001/jamadermatol.2015.1974.

JAMA | 
Editorial | 
Nancy L. Keating, MD, MPH; Lydia E. Pace, MD, MPH
JAMA. 2015;314(15):1569-1571. doi:10.1001/jama.2015.13086.

JAMA | 
From the JAMA Network | 
Min Yi, MD, PhD; Kelly K. Hunt, MD
JAMA. 2015;314(15):1635-1636. doi:10.1001/jama.2015.13149.

JAMA | 
JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2015;314(15):1658. doi:10.1001/jama.2015.11766.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Review  | 
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Oncology
Original Investigation  | 
Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women A Nationwide Cohort Study
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD